Amgen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

13.11.24	Amgen Says No Link Between MariTide And Changes In Bone Mineral Density (RTTNews)
30.10.24	Amgen Inc. Q3 Profit Increases, Beats Estimates (RTTNews)
15.10.24	Amgen Reports Positive Phase 3 Data For Uplizna In Generalized Myasthenia Gravis (RTTNews)
30.09.24	Biotech Stocks Facing FDA Decision In October 2024 (RTTNews)
25.09.24	Amgen's TEPEZZA Approved In Japan For Treatment Of Active Thyroid Eye Disease (RTTNews)
06.08.24	Amgen Inc. Q2 Profit Decreases, But Beats Estimates (RTTNews)
05.06.24	Amgen Reports Positive Results For Phase 3 Trial Of Uplizna For IgG4-RD (RTTNews)
30.05.24	Biotech Stocks Facing FDA Decision In June 2024 (RTTNews)
30.05.24	Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris (RTTNews)
22.05.24	Roche: FDA Grants Breakthrough Device Designation For Bood Test Measuring Lp(a) (RTTNews)
20.05.24	AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment (RTTNews)
17.05.24	Amgen: FDA Approves Imdelltra For Extensive-Stage Small Cell Lung Cancer Treatment (RTTNews)
02.05.24	Amgen Inc. Q1 Earnings Summary (RTTNews)
26.04.24	Amgen Announces Imminent Submission Of MAA To European Medicines Agency For Teprotumumab (RTTNews)
26.02.24	Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs (RTTNews)
06.02.24	Amgen Inc. Q4 Profit Decreases, but beats estimates (RTTNews)
19.01.24	Verastem : Avutometinib Combination Receives Fast Track Designation For KRAS G12C-Mutant NSCLC (RTTNews)
26.12.23	Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS (RTTNews)
26.12.23	AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB) (PR Newswire)
14.12.23	Amgen Appoints David Reese As Chief Technology Officer (RTTNews)
14.12.23	AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION (PR Newswire)
14.12.23	AMGEN TO SPONSOR THE IRISH OPEN (PR Newswire)
13.12.23	FDA Grants Priority Review To Amgen's Application For Small Cell Lung Cancer Treatment (RTTNews)
13.12.23	FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer (PR Newswire)
12.12.23	AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE (PR Newswire)
08.12.23	AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023 (PR Newswire)
30.11.23	Biotech Stocks Facing FDA Decision In December 2023 (RTTNews)
22.11.23	AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE (PR Newswire)
10.11.23	AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023 (PR Newswire)
07.11.23	AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023 (PR Newswire)
07.11.23	AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023 (PR Newswire)
06.11.23	Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition (PR Newswire)
02.11.23	AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE) (PR Newswire)
01.11.23	AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO (PR Newswire)
01.11.23	FDA Approves Amgen's Wezlana For Multiple Inflammatory Diseases (RTTNews)
31.10.23	Amgen Lifts FY23 Adj. Earnings, Revenue Outlook - Update (RTTNews)
31.10.23	Amgen Inc. Q3 Profit Decreases, but beats estimates (RTTNews)
25.10.23	AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS (PR Newswire)
24.10.23	AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND (PR Newswire)
22.10.23	AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER (PR Newswire)
20.10.23	AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER (PR Newswire)
19.10.23	AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023 (PR Newswire)
16.10.23	AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023 (PR Newswire)
06.10.23	Amgen Concludes Horizon Therapeutics Acquisition (RTTNews)
06.10.23	AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC (PR Newswire)
04.10.23	Large-scale proteomics in population-based studies from UK and Iceland (PR Newswire)
20.09.23	AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS (PR Newswire)
11.09.23	AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
10.09.23	Amgen Reports Positive Data From Phase 1 Study Of Lumakras Combination In Non-small Cell Lung Cancer (RTTNews)
10.09.23	AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

20:04		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
17:58		Zurückhaltung in Frankfurt: SDAX beendet die Dienstagssitzung mit Verlusten
17:58		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
17:58		Schwacher Handel in Frankfurt: TecDAX schwächelt zum Handelsende
15:58		Schwacher Handel: SDAX fällt nachmittags
15:58		Minuszeichen in Frankfurt: TecDAX verbucht nachmittags Verluste
15:17		Bayer expandiert: Japan-Lizenz für potenzielles Herzmedikamentenkandidaten gesichert - Aktie tiefer
12:26		Dienstagshandel in Frankfurt: TecDAX präsentiert sich mittags leichter

20:04

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

17:58

Zurückhaltung in Frankfurt: SDAX beendet die Dienstagssitzung mit Verlusten

17:58

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

17:58

Schwacher Handel in Frankfurt: TecDAX schwächelt zum Handelsende

15:58

Schwacher Handel: SDAX fällt nachmittags

15:58

Minuszeichen in Frankfurt: TecDAX verbucht nachmittags Verluste

15:17

Bayer expandiert: Japan-Lizenz für potenzielles Herzmedikamentenkandidaten gesichert - Aktie tiefer

12:26

Dienstagshandel in Frankfurt: TecDAX präsentiert sich mittags leichter

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Amgen Inc.

Aktien Top/Flop

Amgen Peer Group Nachrichten

Meistgelesene Nachrichten